Why Should You Care About Oral Gonorrhea and Oral Human Papillomavirus Infection?
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The incidence of sexually transmitted diseases is increasing with the open-sex culture and as people are having sex at a younger age. Consequently, oral gonorrhea and oral human papillomavirus infections, which are often asymptomatic, result in a high risk of transmission. Oral gonorrhea is symptomatic in less than 20% of patients confirmed by culture for Neisseria gonorrhoeae in both men and women. Even if symptoms develop and oral gonorrhea is diagnosed and treated, the cure rate is less than 90%. Hence, oral gonorrhea can lead to antibiotic resistance to gonorrhea. Oral human papillomavirus infections have received more attention because oral human papillomavirus infections play an important role in the development of oropharyngeal cancer. On the other hand, no test for diagnosing human papillomavirus in the oral cavity has been approved by the US Food and Drug Administration. This lack of test makes it difficult to detect oral human papillomavirus infection early, which can further increase the risk of transmission of human papillomavirus infections. Preventing human papillomavirus infections is very important because surgical resection is the only treatment. Vaccination against human papillomavirus-associated oropharyngeal cancers, including tonsil cancer and base of the tongue cancer, has been reported to be effective in reducing the prevalence of oral human papillomavirus infection in middle-aged adults. Human papillomavirus vaccination is essential for protecting against oral human papillomavirus infection.
Abstract
The incidence of sexually transmitted diseases is increasing with the open-sex culture and as people are having sex at a younger age. Consequently, oral gonorrhea and oral human papillomavirus infections, which are often asymptomatic, result in a high risk of transmission. Oral gonorrhea is symptomatic in less than 20% of patients confirmed by culture for Neisseria gonorrhoeae in both men and women. Even if symptoms develop and oral gonorrhea is diagnosed and treated, the cure rate is less than 90%. Hence, oral gonorrhea can lead to antibiotic resistance to gonorrhea. Oral human papillomavirus infections have received more attention because oral human papillomavirus infections play an important role in the development of oropharyngeal cancer. On the other hand, no test for diagnosing human papillomavirus in the oral cavity has been approved by the US Food and Drug Administration. This lack of test makes it difficult to detect oral human papillomavirus infection early, which can further increase the risk of transmission of human papillomavirus infections. Preventing human papillomavirus infections is very important because surgical resection is the only treatment. Vaccination against human papillomavirus-associated oropharyngeal cancers, including tonsil cancer and base of the tongue cancer, has been reported to be effective in reducing the prevalence of oral human papillomavirus infection in middle-aged adults. Human papillomavirus vaccination is essential for protecting against oral human papillomavirus infection.
참고문헌 (23)
- Fiumara NJ, "Gonorrheal pharyngitis", N Engl J Med, 276, pp.1248~1250 (1967)
- Metzger AL, "Gonococcal arthritis complicating gonorrheal pharyngitis", Ann Intern Med, 73, pp.267~269 (1970)
- Wiesner PJ, "Clinical spectrum of pharyngeal gonococcal infection", N Engl J Med, 288, pp.181~185 (1973)
- Ballini A, "Transmission of nonviral sexually transmitted infections and oral sex", J Sex Med, 9, pp.372~384 (2012)
- Hook EW 3rd, "Kissing, saliva exchange, and transmission of Neisseria gonorrhoeae", Lancet Infect Dis, 19, pp.e367~9 (2019)
- Osborne NG, "Colonization of the pharynx with Neisseria gonorrhoeae : experience in a clinic for sexually transmitted diseases", Sex Transm Dis, 6, pp.253~256 (1979)
- Ratnatunga CS, "Gonococcal pharyngitis", Br J Vener Dis, 48, pp.184~186 (1972)
- Workowski KA, "Sexually transmitted infections treatment guidelines, 2021", MMWR Recomm Rep, 70, pp.1~187 (2021)
- Chow EP, "Prevalence of genital and oropharyngeal chlamydia and gonorrhoea among female sex workers in Melbourne, Australia, 2015-2017 : need for oropharyngeal testing", Sex Transm Infect, 95, pp.398~401 (2019)
- Cornelisse VJ, "Evidence for a new paradigm of gonorrhoea transmission : cross-sectional analysis of Neisseria gonorrhoeae infections by anatomical site in both partners in 60 male couples", Sex Transm Infect, 95, pp.437~442 (2019)
- Ota KV, "Incidence and treatment outcomes of pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections in men who have sex with men : a 13-year retrospective cohort study", Clin Infect Dis, 48, pp.1237~1243 (2009)
- Moran JS, "Drugs of choice for the treatment of uncomplicated gonococcal infections", Clin Infect Dis, 20(Suppl 1), pp.S47~S65 (1995)
- Blomquist PB, "Is gonorrhea becoming untreatable?", Future Microbiol, 9, pp.189~201 (2014)
- Näsman A, "A global epidemic increase of an HPV-induced tonsil and tongue base cancer-potential benefit from a pan-gender use of HPV vaccine", J Intern Med, 287, pp.134~152 (2020)
- Heck JE, "Sexual behaviours and the risk of head and neck cancers : a pooled analysis in the International Head and Neck Cancer Epidemiology(INHANCE)consortium", Int J Epidemiol, 39, pp.166~181 (2010)
- 김성민, "Human papilloma virus in oral cancer", 대한구강악안면외과학회지, 42(6), pp.327~336 (2016), 대한구강악안면외과학회
- Dayyani F, "Meta-analysis of the impact of human papillomavirus(HPV)on cancer risk and overall survival in head and neck squamous cell carcinomas(HNSCC)", Head Neck Oncol, 2, pp.15~ (2010)
- Fakhry C, "Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial", J Natl Cancer Inst, 100, pp.261~269 (2008)
- Bouda M, ""High risk"HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa", Mod Pathol, 13, pp.644~653 (2000)
- Kojima A, "Human papillomavirus type 38 infection in oral squamous cell carcinomas", Oral Oncol, 38, pp.591~596 (2002)
- Kim KS, "Current status of human papillomavirus vaccines", Clin Exp Vaccine Res, 3, pp.168~175 (2014)
- Snow AN, "Human papillomavirus detection in head and neck squamous cell carcinomas", Adv Anat Pathol, 17, pp.394~403 (2010)
- Ramqvist T, "An epidemic of oropharyngeal squamous cell carcinoma(OSCC)due to human papillomavirus(HPV)infection and aspects of treatment and prevention", Anticancer Res, 31, pp.1515~1519 (2011)